Compare CDNA & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | LGIH |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 984.3M |
| IPO Year | 2007 | 2013 |
| Metric | CDNA | LGIH |
|---|---|---|
| Price | $18.20 | $38.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $27.33 | ★ $75.90 |
| AVG Volume (30 Days) | 497.3K | ★ 567.8K |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | $48,324,000.00 | ★ $1,705,504,000.00 |
| Revenue This Year | $16.01 | $6.01 |
| Revenue Next Year | $11.31 | $14.33 |
| P/E Ratio | ★ N/A | $12.21 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $10.96 | $33.55 |
| 52 Week High | $21.49 | $69.42 |
| Indicator | CDNA | LGIH |
|---|---|---|
| Relative Strength Index (RSI) | 53.83 | 37.54 |
| Support Level | $18.30 | $33.55 |
| Resistance Level | $19.14 | $41.50 |
| Average True Range (ATR) | 0.79 | 2.20 |
| MACD | 0.14 | 0.44 |
| Stochastic Oscillator | 76.38 | 50.50 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.